Literature DB >> 2821544

Purification of a membrane-derived human erythroid growth factor.

L Feldman1, C M Cohen, M A Riordan, N Dainiak.   

Abstract

We have purified erythroid burst-promoting activity (BPA) from human lymphocyte plasma membranes by detergent extraction followed by gel-filtration, ion-exchange, and hydroxylapatite chromatography. BPA is a heat-stable integral membrane glycoprotein of Mr 28,000 by gel filtration whose activity is eluted from NaDodSO4/polyacrylamide gels as a broad band at Mr 25,000-29,000. The growth stimulator appears to be erythroid-specific, stimulating proliferation of the human erythroid burst-forming unit (BFU-E) by up to 600% of control values when tested in serum-free bone marrow culture. In contrast, it is devoid of granulocyte/macrophage colony-stimulating factor activity and has a negligible effect on the formation of human megakaryocyte and mixed hematopoietic colonies. Polyclonal anti-lymphocyte membrane IgG, which neutralizes BPA expression in culture, completely absorbs BPA from all lymphocyte-derived sources [solubilized lymphocyte plasma membranes, membrane-containing vesicles shed into lymphocyte conditioned medium (LCM) and soluble vesicle-free LCM supernatants], suggesting that soluble and membrane-derived lymphocyte BPA are antigenically related. This membrane glycoprotein may be an important mediator of proximal cellular interactions that are known to promote erythropoiesis in vitro.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2821544      PMCID: PMC299167          DOI: 10.1073/pnas.84.19.6775

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

Review 1.  The platelet-derived growth factor.

Authors:  R Ross; A Vogel
Journal:  Cell       Date:  1978-06       Impact factor: 41.582

2.  Purification of lymphocytes and platelets by gradient centrifugation.

Authors:  R J Perper; T W Zee; M M Mickelson
Journal:  J Lab Clin Med       Date:  1968-11

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Isolation and characterization of plasma membranes and intact nuclei from lymphoid cells.

Authors:  M Jett; T M Seed; G A Jamieson
Journal:  J Biol Chem       Date:  1977-03-25       Impact factor: 5.157

5.  Silver staining of proteins in polyacrylamide gels.

Authors:  W Wray; T Boulikas; V P Wray; R Hancock
Journal:  Anal Biochem       Date:  1981-11-15       Impact factor: 3.365

6.  Human leukemia cell line K562 responds to erythroid-potentiating activity.

Authors:  C E Gauwerky; A J Lusis; D W Golde
Journal:  Blood       Date:  1982-02       Impact factor: 22.113

7.  Enhancement of the growth of human early erythroid progenitors by bone marrow conditioned media.

Authors:  P N Porter; M Ogawa; A G Leary
Journal:  Exp Hematol       Date:  1980-01       Impact factor: 3.084

8.  Production of erythroid-potentiating activity by a human T-lymphoblast cell line.

Authors:  D W Golde; N Bersch; S G Quan; A J Lusis
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

9.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

Authors:  A E Bolton; W M Hunter
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

10.  Erythroid colony formation in cultures of human marrow: effect of leukocyte conditioned medium.

Authors:  M T Aye
Journal:  J Cell Physiol       Date:  1977-04       Impact factor: 6.384

View more
  5 in total

1.  Intracellular regulation of the production and release of human erythroid-directed lymphokines.

Authors:  N Dainiak; S Sorba
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

2.  Growth factor-dependent initiation of DNA replication in nuclei isolated from an interleukin 3-dependent murine myeloid cell line.

Authors:  N C Munshi; T G Gabig
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

3.  Selective and indirect modulation of human multipotential and erythroid hematopoietic progenitor cell proliferation by recombinant human activin and inhibin.

Authors:  H E Broxmeyer; L Lu; S Cooper; R H Schwall; A J Mason; K Nikolics
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

4.  Characterization of biologically active, platelet-derived growth factor-like molecules produced by murine erythroid cells in vitro and in vivo.

Authors:  A J Sytkowski; C O'Hara; G Vanasse; M J Armstrong; S Kreczko; N Dainiak
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

5.  Acetylated lipoproteins impair erythroid growth factor release from endothelial cells.

Authors:  N Dainiak; H B Warren; S Kreczko; M A Riordan; L Feldman; J Lawler; A M Cohen; P F Davies
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.